Similar articles

• Letter: Gangrene aggravation after use of dopamine.

  Julka NK, Nora JR. Julka NK, et al. JAMA. 1976 Jun 28;235(26):2812-3. JAMA. 1976. PMID: 946980 No abstract available.
• Effectiveness of dopamine in patients with cardiogenic shock.

  Holzer J, Karliner JS, O'Rourke RA, Pitt W, Ross J Jr. Holzer J, et al. Am J Cardiol. 1973 Jul;32(1):79-84. doi: 10.1016/s0002-9149(73)80088-8. Am J Cardiol. 1973. PMID: 4713114 No abstract available.
• Letter: Dopamine gangrene.

  Greene SI, Smith JW. Greene SI, et al. N Engl J Med. 1976 Jan 8;294(2):114. doi: 10.1056/NEJM197601082940221. N Engl J Med. 1976. PMID: 1244497 No abstract available.
• [Catecholamine therapy in cardiogenic shock: helpful, useless or dangerous?].

  Schwertz H, Müller-Werdan U, Prondzinsky R, Werdan K, Buerke M. Schwertz H, et al. Dtsch Med Wochenschr. 2004 Sep 10;129(37):1925-30. doi: 10.1055/s-2004-831364. Dtsch Med Wochenschr. 2004. PMID: 15372372 Review. German.
• Pharmacologic support in cardiogenic shock.

  Rude RE. Rude RE. Adv Shock Res. 1983;10:35-49. Adv Shock Res. 1983. PMID: 6349299 Review.